Description

Clostilbegyt Tablets 50 mg. №10 Vial

Ingredients:

Clostilbegyt tablets contain 50 mg of the active ingredient Clomiphene Citrate. The inactive ingredients include corn starch, lactose, magnesium stearate, and purified water.

Dosage:

The recommended dosage of Clostilbegyt is 50 mg (1 tablet) daily for 5 days, starting on the 5th day of the menstrual cycle. Dosage may be adjusted by a healthcare provider based on individual response.

Indications:

Clostilbegyt is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. It is used to induce ovulation in those who do not ovulate regularly.

Contraindications:

Do not use Clostilbegyt if you are pregnant, have liver disease, abnormal uterine bleeding, ovarian cysts, or hypersensitivity to the drug. It is important to discuss all medical conditions with your healthcare provider before starting treatment.

Directions:

Take Clostilbegyt exactly as prescribed by your doctor. Swallow the tablet whole with a full glass of water. Follow your doctor’s instructions carefully and do not exceed the recommended dosage.

Scientific Evidence:

Clostilbegyt has been extensively studied for its efficacy in inducing ovulation. Research has shown that Clomiphene Citrate, the active ingredient in Clostilbegyt, effectively stimulates the release of gonadotropins, which in turn triggers ovulation in women with ovulatory dysfunction.

Additional Information:

It is important to undergo regular monitoring and evaluation by a healthcare provider while taking Clostilbegyt to assess the response to treatment and adjust the dosage if needed. This medication should only be used under medical supervision to ensure safety and efficacy.

Pharmacologically, Clostilbegyt works by binding to estrogen receptors in the hypothalamus, leading to an increase in follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release. This hormonal surge stimulates ovarian follicle growth and ovulation.

Clostilbegyt has been compared to other ovulation-inducing agents in clinical trials, demonstrating similar effectiveness with a favorable side effect profile. Studies have shown that Clostilbegyt is well-tolerated and can be a first-line treatment option for women with ovulatory dysfunction.